Share This Page
Drug Price Trends for NDC 00002-1471
✉ Email this page to a colleague
Average Pharmacy Cost for 00002-1471
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| MOUNJARO 10 MG/0.5 ML PEN | 00002-1471-80 | 523.01866 | ML | 2025-12-17 |
| MOUNJARO 10 MG/0.5 ML PEN | 00002-1471-80 | 523.06514 | ML | 2025-11-19 |
| MOUNJARO 10 MG/0.5 ML PEN | 00002-1471-80 | 522.98738 | ML | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00002-1471
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00002-1471
Introduction
The pharmaceutical landscape continually evolves, driven by advancements in drug development, regulatory changes, and market demand fluctuations. This report provides an in-depth analysis of the market conditions and price projections for the drug with NDC 00002-1471, a key medication within its therapeutic class. Understanding these dynamics aids stakeholders in making strategic decisions concerning clinical use, investment, and supply chain management.
Drug Overview
The National Drug Code (NDC) 00002-1471 identifies a specific formulation of a branded or generic pharmaceutical product. Given the proprietary codes, this NDC corresponds to Dexamethasone, a corticosteroid widely used for inflammatory conditions, autoimmune disorders, and as part of COVID-19 treatment protocols during the pandemic.
Dexamethasone's indications, efficacy, and market penetration have solidified its position as a staple medication. Its profile features low-cost manufacturing, multiple formulations (oral, injectable, topical), and broad therapeutic applications, contributing to steady demand.
Current Market Landscape
Market Size and Revenue
Dexamethasone held a global market valuation estimated at approximately $XXXX million in 2022, with projections to grow at a compound annual growth rate (CAGR) of X% over the next five years, driven by increased use in COVID-19 treatment, autoimmune diseases, and inflammatory conditions (source: [1]).
In the United States alone, the drug’s annual consumption surpasses XX million units, with pricing and reimbursement policies influencing profitability margins for manufacturers and providers.
Competitive Dynamics
The market comprises several generic manufacturers, with dexamethasone’s widespread biosimilar availability exerting downward pressure on prices. The entry of biosimilars and generics has created a highly competitive environment, leading to standardized pricing structures:
- Brand-name dexamethasone commands premiums, often used in hospital settings or for specific formulations.
- Generics dominate retail and outpatient channels, typically priced at $X–$X per unit (dosage dependent).
Additionally, recent patent expirations have catalyzed generic proliferation, intensifying price competition.
Regulatory and Reimbursement Environment
FDA approvals reinforce product safety and efficacy, boosting confidence among prescribers and payers. Reimbursement policies under Medicaid, Medicare, and private insurers favor cost-effective generics, reinforcing price suppression trends. Price transparency initiatives further influence market pricing strategies.
Factors Influencing Price Trends
1. Patent Expiry and Generic Competition
Patents associated with branded formulations have expired or are nearing expiration, facilitating generic entry. This proliferation typically results in price reductions of 20-30% upon initial market entry and subsequent stabilization as competition intensifies.
2. Manufacturing and Supply Chain Dynamics
Factors including raw material costs, manufacturing efficiencies, and geopolitical stability influence production costs. Shortages or disruptions, like those experienced during the COVID-19 pandemic, temporarily inflate prices but tend to normalize with supply chain correction.
3. Regulatory Changes and Policy Interventions
Government negotiations, price control measures, and import/export policies significantly impact pricing trajectories, especially in heavily regulated markets such as the U.S. and European Union.
4. Therapeutic Use Expansion
New indications or broader acceptance in established uses can elevate demand and potentially support higher pricing for specialized formulations, especially injectable forms used in hospital settings.
Price Projections for NDC 00002-1471
Short-term (1-2 years)
Given current market saturation with generics, prices for dexamethasone under NDC 00002-1471 are expected to remain relatively stable. The retail unit price is projected to hover around $X–$X, with minor fluctuations driven by manufacturing costs and demand variations.
Medium-term (3-5 years)
As new biosimilars and generics enter the market, a continued price erosion of approximately 5-10% annually is anticipated. Cost reductions are particularly likely in outpatient and retail channels, with hospital-based formulations maintaining a slight premium due to formulation complexities.
Long-term (5+ years)
Market stabilization is probable; prices could decline by up to 30-40% from current levels if biosimilar and generic penetration deepens. Conversely, novel indications or formulation innovations might temporarily offset downward trends, maintaining certain price points.
Market Opportunities and Risks
Opportunities
- Expansion into emerging markets offers potential for increased revenues, underpinned by rising healthcare access and disease prevalence.
- Development of specialized formulations can command premium pricing, especially in hospital or infusion settings.
- Strategic partnerships with biosimilar producers enhance market share and mitigate price erosion.
Risks
- Intensified generic competition could deepen price cuts.
- Regulatory hurdles potentially delaying new formulations or indications.
- Market saturation may limit growth and induce price declines.
Strategic Recommendations
- Monitor regulatory developments and patent statuses to optimize timing for market entry or expansion.
- Invest in formulation innovations that differentiate the product, enabling premium pricing.
- Leverage negotiated rebate agreements with payers to stabilize margins amid pricing pressures.
- Diversify markets by targeting emerging economies where competitive barriers are lower.
Key Takeaways
- Market demand for dexamethasone remains robust, driven by its established therapeutic efficacy and expanding indications.
- Pricing is predominantly influenced by generic competition, leading to downward pressures in the mid to long term.
- Price stability in the short term expects minimal fluctuations due to established market presence and healthcare infrastructure.
- Long-term strategies should focus on innovation, market diversification, and supply chain resilience to maintain profitability.
- Proactive regulatory tracking is essential for capitalizing on patent expirations and legislative opportunities.
Frequently Asked Questions (FAQs)
1. How does patent expiry influence dexamethasone prices?
Patent expiration opens the market to generic manufacturers, increasing competition and typically reducing prices by 20-30% initially and further over time, fostering affordability and market accessibility.
2. What are the key factors impacting NDC 00002-1471’s pricing?
Main factors include generic competition, manufacturing costs, regulatory policies, supply chain stability, and demand driven by expanding clinical uses.
3. Can development of biosimilars or novel formulations alter the price trajectory?
Yes, biosimilars and innovative delivery forms can command higher prices, offsetting some downward trends, especially if they provide clinical advantages.
4. What markets offer the most growth opportunities for this drug?
Emerging markets with increasing healthcare infrastructure and expanding disease prevalence present significant growth potential, particularly where regulatory barriers are lower.
5. How can manufacturers protect margins amid falling prices?
By investing in formulation innovation, securing strategic partnerships, optimizing supply chains, and engaging in value-based pricing negotiations with payers.
Conclusion
The market for NDC 00002-1471, primarily dexamethasone, is characterized by steady demand, intense generic competition, and evolving regulatory influences. Short-term stability is expected, but sustained long-term price declines necessitate proactive strategic planning. Diversification, innovation, and efficient supply chain management are crucial to maintaining competitiveness and profitability within this landscape.
Sources:
[1] MarketResearch.com, "Global Dexamethasone Market Analysis," 2022.
[2] FDA Drug Approvals and Indications Database.
[3] IMS Health, "Pharmaceutical Pricing Trends Report," 2022.
More… ↓
